At reproductive centers in Kyrgyzstan, when determining a medication protocol, the first thing a doctor does is not prescribe medication, but look at a chart: AMH, FSH, LH, E2, Antral Follicle Count (AFC), and history of previous ovarian response. This chart determines what the patient needs to inject daily for the next 10-12 days, the dosage, and when to trigger ovulation. There is no "one-size-fits-all template" for medication protocols, only "individualized decisions."
IVF Medication Protocols in Kyrgyzstan: What is the Core?
Reproductive centers in Kyrgyzstan primarily use the GnRH antagonist protocol and the mild stimulation protocol. Some patients with very low ovarian reserve or advanced age may use a mini-stimulation protocol or a natural cycle protocol. Medication is based on injectable gonadotropins (FSH+LH), combined with a GnRH antagonist to prevent premature ovulation. Ovulation trigger is usually achieved with hCG or a GnRH agonist.
Unlike some centers in China, long protocols or ultra-long protocols are less commonly used here. The reason is that among the patient population in Kyrgyzstan, a high proportion are cross-border medical travelers with tight schedules, and ovarian function tends to be more complex (high rates of advanced age, repeated failures, poor ovarian response), requiring more flexible, shorter-duration protocols.
How Do Local Doctors Decide on a Medication Protocol?
When formulating a protocol, reproductive doctors primarily rely on the following three dimensions:
- Ovarian Reserve Function: AMH, AFC, and FSH are core indicators. AMH > 1.2 ng/mL, AFC > 7: antagonist protocol is preferred; AMH 0.5-1.2:倾向于 mild stimulation or mini-stimulation; AMH < 0.5: usually natural cycle or mini-stimulation.
- Age: Under 35 with normal ovarian function: standard antagonist protocol; 35-40 years old: adjust starting dose based on AMH; Over 40: regardless of AMH, mild stimulation or natural cycle is prioritized.
- Previous Response: If previous stimulation resulted in Ovarian Hyperstimulation Syndrome (OHSS), the dose will be lowered this time or an agonist trigger will be used; if previous response was poor (fewer than 3 eggs retrieved), an attempt will be made to increase the starting FSH dose or switch medication brands.
Easily Overlooked Details in Medication
Medication Brand Differences: The ovulation induction drugs used in Kyrgyzstan are mainly European brands (Merck, Organon, Ferring), which differ in bioefficacy from commonly used Chinese brands like Lishenbao and Gonal-f. Dosage conversion cannot be simply copied. Local doctors are more familiar with Gonal-F, Menopur, and Pergoveris. Patients bringing medication from China need to communicate in advance.
Injection Time Window: Local clinics usually require ovulation induction injections to be fixed between 18:00 and 21:00, differing from many centers in China that schedule them in the morning. This is to coordinate with the antagonist injection time and ensure egg retrieval surgery is scheduled in the optimal morning window. A time fluctuation exceeding 30 minutes may affect follicular development synchrony.
Luteal Phase Support Method: In Kyrgyzstan, oral dydrogesterone plus vaginal progesterone gel is commonly used, instead of intramuscular progesterone injections commonly used in China. Reasons include reducing injection pain and higher bioavailability of vaginally administered progesterone. However, some patients have variable absorption with vaginal medication, requiring progesterone level monitoring.
Differences in Medication Strategies by Age Group
| Age | Common Protocol | Starting Dose (FSH) | Antagonist Timing | Trigger Method |
|---|---|---|---|---|
| < 35 years | Antagonist Protocol | 150-225 IU | When follicles ≥ 12mm | hCG or Agonist |
| 35-40 years | Antagonist / Mild Stimulation | 225-300 IU | When follicles ≥ 12mm | hCG |
| > 40 years | Mild Stimulation / Mini-Stimulation / Natural Cycle | 150-225 IU (or lower) | Based on follicular development | hCG or Agonist |
It should be noted that the above dosages are common ranges. Local doctors tend to follow the "start low, go slow" principle, especially for those with low ovarian reserve, to avoid overstimulation leading to decreased egg quality.
Three Most Common Pitfalls
- Self-Adjusting Dosage: Some patients think "if follicles are growing slowly, I'll add medication myself." This is dangerous. Excess FSH can lead to overdevelopment of follicles, decreased quality, and even OHSS. Dose adjustments must be based on E2 levels and ultrasound monitoring.
- Missing or Delaying Antagonist Injection: The antagonist injection time is fixed. If delayed by more than 2 hours, the risk of premature ovulation significantly increases. Local clinics repeatedly emphasize setting alarm reminders.
- Misjudging Trigger Timing: Kyrgyzstan doctors usually wait until the leading follicles reach 18-22mm to trigger, but the trigger window varies by protocol. For example, when using an agonist trigger, the average follicle diameter needs to be above 20mm, and E2 levels must match the follicle count. Misjudgment can lead to empty follicles or low egg retrieval rates.
Medication Process: From Start to Egg Retrieval
Below is a typical medication process for an antagonist protocol in Kyrgyzstan:
- Start Day (Menstrual Cycle Day 2-3): Transvaginal ultrasound confirms no cysts, E2 level is adequate. Begin FSH injections (commonly Gonal-F or Menopur) at a fixed time daily.
- Monitoring Day (Medication Day 5-6): Ultrasound + E2 monitoring to assess follicle count and size, adjust FSH dose. The antagonist (Cetrotide or Orgalutran) is usually started at this point, administered at a fixed time daily.
- Continued Monitoring (Medication Day 7-10): Monitoring every 1-2 days to observe follicular growth rate and E2 rise trend. Continue antagonist injections until the trigger day.
- Trigger Day (Medication Day 10-12): When at least 2 follicles are ≥ 18mm and E2 matches the follicle count, inject hCG (Ovidrel or Pregnyl) or GnRH agonist (Decapeptyl).
- Egg Retrieval Day (34-36 hours after trigger): Transvaginal ultrasound-guided egg retrieval.
Medication Timeline: What Needs Advance Planning?
A complete medication cycle typically requires:
- Pre-treatment Tests: Complete AMH, sex hormone panel, semen analysis, and infectious disease screening at least 1 month in advance. Local clinics accept test reports within 3 months.
- Medication Cycle: From start to egg retrieval, a total of 10-12 days. It is recommended to reserve 14 days in Kyrgyzstan to handle unexpected situations (e.g., slow follicular growth requiring extended medication).
- Medication Preparation: Some medications need refrigeration (e.g., antagonists). Confirm that accommodation has a refrigerator. Local pharmacies can supply some medications, but it is advisable to check stock in advance.
- Luteal Phase Support: Begins on the day of egg retrieval and continues until the pregnancy test day. If pregnancy is confirmed after transfer, luteal support must continue until 10-12 weeks of gestation.
Medication Adjustments in Special Situations
PCOS Patients: Due to high OHSS risk, local doctors prioritize mild stimulation protocols, reducing the starting FSH dose to 75-112.5 IU, and strictly monitoring E2 levels and follicle count. GnRH agonist trigger is mandatory instead of hCG to reduce OHSS incidence.
Poor Ovarian Response (POR): AMH < 0.5, AFC < 3. These patients typically use a mini-stimulation protocol (Clomid + low-dose FSH) or a natural cycle protocol. The goal is to obtain 2-3 high-quality eggs rather than quantity. Local doctors will not increase FSH dosage to improve egg yield, as excess FSH is more detrimental than beneficial for egg quality in low responders.
Previous Repeated Failure: For patients with more than 2 previous failed transfers, doctors focus more on endometrial receptivity and embryo quality. They may add growth hormone (GH) to the protocol or use a mild stimulation protocol to try to improve oocyte mitochondrial function. The currently available human growth hormone brand locally is Zomacton.
Interpretation of Medication-Related Test Indicators
| Indicator | Normal Reference Range | Significance for Medication Decisions |
|---|---|---|
| AMH | 1.2-4.0 ng/mL | Determines the type of stimulation protocol and starting dose |
| FSH | 3-10 IU/L | FSH > 10 indicates diminished ovarian reserve, requiring cautious medication |
| LH | 2-9 IU/L | LH/FSH ratio > 2 may indicate PCOS, requiring antagonist protocol adjustment |
| E2 | 30-100 pg/mL (follicular phase) | Starting day E2 level must match follicle count; too high may indicate a cyst |
| Antral Follicle Count (AFC) | > 7 | AFC < 5 usually不建议 standard stimulation; switch to mild stimulation |
Case Study: Medication Protocol Choice for a 39-Year-Old Patient with AMH 0.8
Patient Profile: 39 years old, AMH 0.8 ng/mL, AFC 4, no previous stimulation history. Consulted at a center in Bishkek.
Doctor's Decision: Adopted a mild stimulation protocol, starting FSH dose 225 IU, added antagonist on day 5, triggered with hCG. Result: 4 eggs retrieved, 3 mature, 2 fertilized, 1 blastocyst formed, successful pregnancy after transfer.
Key Point: For patients with AMH < 1.0, local doctors do not pursue egg quantity. Instead, through individualized dosing and close monitoring, they strive to obtain better quality eggs. If a standard antagonist protocol (300 IU FSH) had been used, although 5-6 eggs might have been retrieved, egg maturity and fertilization rates could have been lower.
Practitioner Observation: Local Medication Trends
Over the past 3 years, medication protocols at Kyrgyzstan reproductive centers have seen some changes:
- Antagonist protocols now account for over 70%, with long protocols nearly phased out due to their shorter cycle, higher flexibility, and better patient experience.
- Mild stimulation protocol usage is rising in older patients, increasing from 20% in 2021 to 45% in 2024. More doctors recognize that "quality eggs matter more than quantity."
- Medication dosages are becoming more individualized, with algorithm models based on AMH and AFC being adopted by more doctors rather than empirical dosing.
- Patient education levels are improving, with more cross-border patients researching medication protocols in advance and discussing individualized details with doctors for shared decision-making.
Frequently Asked Questions About Medication Protocols
Q: Are the ovulation induction drugs in Kyrgyzstan the same as in China?
A: Some are the same, but brands and specifications differ. Common local brands include Gonal-F, Menopur, and Pergoveris. Common Chinese brands include Lishenbao, Jinsaiheng, and Gonal-F. It is recommended to have the local doctor provide a medication list after the protocol is decided, then decide whether to bring your own or purchase locally.
Q: Do I need to follow a special diet during medication?
A: No special diet is required, but it is advisable to avoid high-sugar, high-fat foods and ensure adequate protein intake. Local doctors usually recommend increasing intake of deep-sea fish, eggs, and soy products to provide nutrients for follicular development.
Q: Will ovulation induction injections cause weight gain?
A: During stimulation, elevated estrogen levels can cause water and sodium retention, leading to a temporary weight increase of 2-4 jin (1-2 kg). This will resolve after menstruation following the medication stop. This is not actual fat gain, so no dietary reduction is needed.
Q: What if I find my follicles are growing slowly during medication?
A: Do not add medication yourself. The doctor will decide whether to increase the FSH dose or extend the medication days based on E2 levels and follicle diameters. Usually, medication days 5-6 are the adjustment window. Follicle growth speed varies individually.
Risk Reminder: Any ovulation induction protocol carries risks of OHSS, ovarian torsion, infection, bleeding, etc., but the incidence is low under standardized monitoring. Reproductive centers in Kyrgyzstan must perform at least 3 ultrasound + E2 monitoring sessions during medication, which is core to ensuring safety. If choosing IVF treatment abroad, ensure you select a正规 center with laboratory and emergency management capabilities.
Recommendation: Before starting medication, discuss the following questions in detail with your primary doctor:
- Given my AMH and AFC, which protocol is most suitable?
- What is the starting dose? What are the criteria for dose adjustment?
- From which day is the antagonist started? What are the consequences of delay?
- What is the trigger method? Under what conditions would the trigger method be changed?
- What is the luteal phase support plan? How long does it need to continue?
There is no single "best" medication protocol, only the most suitable one. Individualized medication is the core of assisted reproduction and the foundation for improving success rates.